Education
About Us
Working with TipRanks
Follow Us
InterCure (IL:INCR)
:INCR
INCR Stock Chart & Stats
Day’s Range― - ―
52-Week Range454.10 - 1,346.00
Previous CloseN/A
Volume249.40K
Average Volume (3M)78.25K
Market Cap
$252.32M
Enterprise ValueN/A
Total Cash (Recent Filing)3.61M
Total Debt (Recent Filing)1.32M
Price to Earnings (P/E)―
Beta1.48
Next Earnings
Apr 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding47,162,712
10 Day Avg. Volume52,828
30 Day Avg. Volume78,253
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Intercure News
PremiumCompany Announcements
InterCure Announces Leadership Change and Secures $18.2 Million Financing
PremiumCompany Announcements
Intercure Releases Detailed Land and Financial Report
PremiumCompany Announcements
InterCure Secures Major Funding to Boost Growth
---
INCR FAQ
What was InterCure’s price range in the past 12 months?
InterCure lowest stock price was 454.10 and its highest was 1346.00 in the past 12 months.
What is InterCure’s market cap?
InterCure’s market cap is $252.32M.
When is InterCure’s upcoming earnings report date?
InterCure’s upcoming earnings report date is Apr 07, 2025 which is in 6 days.
How were InterCure’s earnings last quarter?
Currently, no data Available
Is InterCure overvalued?
According to Wall Street analysts InterCure’s price is currently Overvalued.
Does InterCure pay dividends?
InterCure does not currently pay dividends.
What is InterCure’s EPS estimate?
InterCure’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InterCure have?
InterCure has 47,162,712 shares outstanding.
What happened to InterCure’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of InterCure?
Currently, no hedge funds are holding shares in IL:INCR
---
Intercure Stock Smart Score
Company Description
InterCure
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.
---
INCR Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering INCR
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-54.80%
initiated a buy rating 10 months ago
Copying Pablo Zuanic's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -54.80% per trade.
---